News
The study found that 100 per cent of patients were responsive and 92 per cent went into remission
Hi, what are you looking for?
Mugglehead Investment Magazine
Psychedelics
Psychedelics
The company focuses on developing novel psychoactive drugs with more gentle effects
Psychedelics
It now has 19 million shares of the psychedelic drug developer, the firm's first investment in a public entity of this variety
News
The study findings represent the culmination of more than two decades of dedicated research efforts
Psychedelics
Funds will be used to study psilocybin and MDMA-assisted therapy; non-profit says Sweden needs to 'catch up' in this area of research
News
Silo's SPC-15 was developed in collaboration with Columbia University
News
Lucy expects to complete the acquisition within 90 days
Psychedelics
The paper in the journal Psychopharmacology concluded that a machine learning algorithm could predict treatment efficacy
News
Johns Hopkins University School of Medicine is the second U.S. clinical site to join Clearmind's trial, following Yale School of Medicine's psychiatry department
Psychedelics
The MDMA producer is now trading under the symbol PMBHF, which is intended to attract more investors in the U.S.
